Literature DB >> 28070914

Risk of Cesarean scar defect following single- vs double-layer uterine closure: systematic review and meta-analysis of randomized controlled trials.

A Di Spiezio Sardo1, G Saccone2, R McCurdy3, E Bujold4, G Bifulco2, V Berghella3.   

Abstract

OBJECTIVE: There is a growing body of evidence that suggests that the surgical technique for uterine closure following Cesarean delivery influences the healing of the Cesarean scar, but there is still no consensus on the optimal technique. The aim of this systematic review and meta-analysis was to compare the effect of single- vs double-layer uterine closure on the risk of uterine scar defect.
METHODS: MEDLINE, Scopus, ClinicalTrials.gov, PROSPERO, EMBASE and the Cochrane Central Register of Controlled Trials were searched from inception of each database until May 2016. All randomized controlled trials (RCTs) evaluating the effect of single- vs double-layer uterine closure following low transverse Cesarean section on the risk of uterine scar defect were included. The primary outcome was the incidence of uterine scar defects detected on ultrasound. Secondary outcomes were residual myometrial thickness evaluated by ultrasound and the incidence of uterine dehiscence and/or rupture in subsequent pregnancy. Summary measures were reported as relative risk (RR) or mean difference (MD), with 95% CIs. Quality of the evidence was assessed using the GRADE approach.
RESULTS: Nine RCTs (3969 participants) were included in the meta-analysis. The overall risk of bias of the included trials was low. Statistical heterogeneity within the studies was low, with no inconsistency in the primary and secondary outcomes. Women who received single-layer uterine closure had a similar incidence of uterine scar defects as did women who received double-layer closure (25% vs 43%; RR, 0.77 (95% CI, 0.36-1.64); five trials; 350 participants; low quality of evidence). Compared with double-layer uterine closure, women who received single-layer closure had a significantly thinner residual myometrium on ultrasound (MD, -2.19 mm (95% CI, -2.80 to -1.57 mm); four trials; 374 participants; low quality of evidence). No difference was found in the incidence of uterine dehiscence (0.4% vs 0.2%; RR, 1.34 (95% CI, 0.24-4.82); three trials; 3421 participants; low quality of evidence) or uterine rupture (0.1% vs 0.1%; RR, 0.52 (95% CI, 0.05-5.53); one trial; 3234 participants; low quality of evidence) in a subsequent pregnancy.
CONCLUSIONS: Single- and double-layer closure of the uterine incision following Cesarean delivery are associated with a similar incidence of Cesarean scar defects, as well as uterine dehiscence and rupture in a subsequent pregnancy. However, the quality level of summary estimates, as assessed by GRADE, was low, indicating that the true effect may be, or is even likely to be, substantially different from the estimate of the effect.
Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  isthmocele; minimally invasive therapy; niche; scar defects; scar pregnancy; ultrasound

Mesh:

Year:  2017        PMID: 28070914     DOI: 10.1002/uog.17401

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  12 in total

1.  The diagnostic value of 3.0T MRI in cesarean scar pregnancy.

Authors:  Shuning Guo; Haitao Wang; Xiuying Yu; Yang Yu; Chunguo Wang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 3.940

2.  Outcomes after Hysteroscopic Treatment of Symptomatic Isthmoceles in Patients with Abnormal Uterine Bleeding and Pelvic Pain: A Prospective Case Series.

Authors:  Ana Vegas Carrillo de Albornoz; Irene López Carrasco; Nerea Montero Pastor; Carmen Martín Blanco; María Miró Matos; Luis Alonso Pacheco; Enrique Moratalla Bartolomé
Journal:  Int J Fertil Steril       Date:  2019-04-27

3.  Efficacy of adjunctive azithromycin versus single-dose cephalosporin prophylaxis for caesarean scar defect: study protocol for a randomised controlled trial.

Authors:  Yanqing Cai; Hongjie Pan; Jian Zhang; Weiwei Cheng; Yiru Shi; Min Zeng; Liye Shi; Jin Yu; Ying Shen; Shan Chen; Qian Zhu; Ben W Mol; Ding Huang
Journal:  BMJ Open       Date:  2020-01-07       Impact factor: 2.692

4.  Post-Caesarean section niche-related impaired fertility: hypothetical mechanisms.

Authors:  Jolijn Vissers; Wouter Hehenkamp; Cornelis Bavo Lambalk; Judith Anna Huirne
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

5.  Transplantation of human amniotic epithelial cells promotes morphological and functional regeneration in a rat uterine scar model.

Authors:  Yihui Fan; Junyan Sun; Qiuwan Zhang; Dongmei Lai
Journal:  Stem Cell Res Ther       Date:  2021-03-24       Impact factor: 6.832

6.  Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy.

Authors:  Wenyang Zhu; Xiaofang Zhang; Chang Liu; Yang Liu; Wei Xu
Journal:  Front Surg       Date:  2022-02-02

7.  Laparoscopic Fluorescence Guided Detection of Uterine Niche-The Next Step in Surgical Diagnosis and Treatment.

Authors:  Harald Krentel; Lisa-Kathrin Lauterbach; Georgios Mavrogiannis; Rudy Leon De Wilde
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.241

8.  Comparison of the effect of skin closure materials on skin closure during cesarean delivery.

Authors:  Ye Huang; Xinbo Yin; Junni Wei; Suhong Li
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

9.  The Case for Standardizing Cesarean Delivery Technique: Seeing the Forest for the Trees.

Authors:  Joshua D Dahlke; Hector Mendez-Figueroa; Lindsay Maggio; Jeffrey D Sperling; Suneet P Chauhan; Dwight J Rouse
Journal:  Obstet Gynecol       Date:  2020-11       Impact factor: 7.623

Review 10.  Maternal and Fetal Outcomes after Prior Mid-Trimester Uterine Rupture: A Systematic Review with Our Experience.

Authors:  Shinya Matsuzaki; Tsuyoshi Takiuchi; Takeshi Kanagawa; Satoko Matsuzaki; Misooja Lee; Michihide Maeda; Masayuki Endo; Tadashi Kimura
Journal:  Medicina (Kaunas)       Date:  2021-11-24       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.